AI / ML Innovations Announces Results of Early Mandate Incentive Program | 2021-10-13 | Press Releases

TORONTO, ON / ACCESSWIRE / October 13, 2021 / AI / ML Innovations Inc. (CSE: AIML; OTCQB: AIMLF; FWB: 42FB), a company committed to acquiring and advancing artificial intelligence / machine learning technologies that meet the pressing needs of the company, is pleased to announce that its previously announced anticipated exercise of the Incentive Program (the “Program”) has been successfully completed. As a result of the program, 2,288,000 warrants were exercised, resulting in the issuance of 1,144,000 common shares from treasury and the raising of $ 572,000 in working capital for the Company.

About IA / ML Innovations Inc.

AI / ML Innovations Inc. has realigned its business operations to capitalize on the growing areas of Artificial Intelligence (AI) and Machine Learning (ML), with an initial investment focused on emerging healthcare and healthcare companies. digital wellness that leverage AI, ML, and cloud computing. and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (70% owned by AIML), Tech2Heal (22% owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding areas of growth, for the benefit of all stakeholders in the company. AI / ML shares trade on the Canadian Stock Exchange under the symbol “AIML”, on the OTCQB Venture Market under “AIMLF” and on the Frankfurt Stock Exchange under “42FB”.

On behalf of the board of directors

Tim Daniels, Executive Chairman

For more information on AI / ML innovations:

For detailed information, please see AI / ML’s website at or company filings at

For more information: Blake Fallis at (778) 405-0882 or [email protected]


Corporate video:

Official YouTube channel:

Neither CSE nor its regulatory services provider (as that term is defined in CSE policies) accepts responsibility for the adequacy or accuracy of this release.

THE SOURCE: AI / ML Innovations Inc.

See the source version on

Source link

Comments are closed.